MM2-thalamic Creutzfeldt-Jakob disease: neuropathological, biochemical and transmission studies identify a

Fabio Moda1, Silvia Suardi, Giuseppe Di Fede

  • 1Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Insights

Creutzfeldt-Jakob disease (CJD) subtypes are linked to prion protein (PrPSc) types and PRNP gene variations. MM2-thalamic CJD, unlike the cortical form, transmits to mice, indicating a distinct prion strain.

Area of Science:

  • Neuroscience
  • Prion Diseases
  • Molecular Biology

Background:

  • Creutzfeldt-Jakob disease (CJD) classification relies on protease-resistant prion protein (PrPSc) size and PRNP codon 129 polymorphism.
  • Sporadic CJD (sCJD) subtypes correlate with distinct clinical and pathological features.
  • MM2-thalamic CJD is a rare subtype, previously grouped with sporadic fatal insomnia.

Observation:

  • Two young patients presented with MM2-thalamic CJD.
  • Neuropathology revealed diffuse PrP immunoreactivity in the cortex and severe thalamic/olivary nucleus damage.
  • Western blot confirmed type 2A PrPSc in affected individuals.

Findings:

  • Transgenic mice expressing 129MM human PrP successfully transmitted MM2-thalamic sCJD.
  • MM2-cortical sCJD did not transmit to the same mouse model.
  • Affected mice exhibited unprecedented type 2A PrPSc deposition, distinct from other sCJD subtypes.

Implications:

  • MM2-thalamic sCJD represents a unique prion strain, separable from MM2-cortical sCJD.
  • This finding refines the understanding of CJD prion diversity and classification.
  • Further research into prion strain characteristics is crucial for CJD diagnosis and therapeutic strategies.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...